Evidence map›Paper›PMID 35421276›Full record

ArticleJournal of clinical laboratory analysis2022

LncRNA TUG1 functions as a ceRNA for miR-1-3p to promote cell proliferation in hepatic carcinogenesis.

Keke Tang, Di Lv, Lingling Miao, Yushan Mao, Xiaoyan Yu

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical laboratory analysis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Deciphering the role ofWorld journal of hepatology · 2025
    Review
  4. Article
  5. Frontiers in microbiology · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. The important role of miR-1-3p in cancers.Journal of translational medicine · 2023
    Review
  11. Journal of gastrointestinal oncology · 2023
    Article
  12. Frontiers in genetics · 2023
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Keke TangThe Affiliated Hospital of the Medical School of Ningbo University, Ningbo, China.ORCID https://orcid.org/0000-0002-8485-1026
Di LvThe Affiliated Hospital of the Medical School of Ningbo University, Ningbo, China.
Lingling MiaoThe Affiliated Hospital of the Medical School of Ningbo University, Ningbo, China.
Yushan MaoThe Affiliated Hospital of the Medical School of Ningbo University, Ningbo, China.
Xiaoyan YuThe Affiliated Hospital of the Medical School of Ningbo University, Ningbo, China.
Ningbo University · CN

Funding

Medical Science and Technology Planning Project of the Ningbo Bureau of Science and Technology 2017A18Ningbo Science and Technology Planning Project 2019A610271
6 · The paper itself

Abstract

backgroundHepatocellular carcinoma (HCC) is characterised by high malignancy, metastasis and recurrence, but the specific mechanism that drives these outcomes is unclear. Recent studies have shown that long noncoding RNAs (lncRNAs) can regulate the proliferation and apoptosis of hepatic cells.

methodsWe searched for lncRNAs and microRNAs (miRNAs), which can regulate IGF1 expression, through a bioinformatics website, and predicted that lncRNA taurine-upregulated gene 1 (TUG1) would have multiple targets for miR-1-3p binding, meaning that lncRNA TUG1 played an adsorption role. A double luciferase assay was used to verify the targeting relationship between lncRNA TUG1 and miR-1-3p. Western blotting and qPCR were used to verify the targeting relationship between miR-1-3p and IGF1, and qPCR was used to verify the regulatory relationship between the lncRNA TUG1-miR-1-3p-IGF1 axis. CCK-8 was used to detect the growth activity of miRNA-transfected L-O2 cells, and flow cytometry was used to detect cell cycle changes and apoptosis.

resultThe proliferation cycle of L-O2 cells transfected with miR-1-3p mimics was significantly slowed. Flow cytometry showed that the proliferation of L-O2 cells was slowed, and the apoptosis rate was increased. In contrast, when L-O2 cells were transfected with miR-1-3p inhibitor, the expression of IGF1 was significantly upregulated, and the cell proliferation cycle was significantly accelerated. Flow cytometry showed that the cell proliferation rate was accelerated, and the apoptosis rate was reduced.

conclusionLncRNA TUG1 can adsorb miR-1-3p as a competitive endogenous RNA (ceRNA) to promote the expression of IGF1 and promote cell proliferation in hepatic carcinogenesis.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsMicroRNAsRNA, Long NoncodingApoptosisCarcinogenesisCell Line, TumorCell ProliferationHumansMicroRNAsMIRN1 microRNA, humanRNA, Long NoncodingTUG1 long noncoding RNA, humancell apoptosiscell proliferationIGF1LncRNA TUG1miR-1-3p

Identifiers

PMID35421276
PMCPMC9102766
OpenAlexW4224018499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.